-transparent.png){kind=logo}
Resistance to chemotherapy is a significant problem in the treatment of colorectal carcinomas. To obtain insight into the mechanism of drug resistance, the expression of P-170 glycoprotein and biotransformation enzymes that are potentially able to contribute to drug resistance were investigated in paired samples of normal mucosa and tumors from 24 patients with colorectal cancer. In the tumors, glutathione S-transferase (GST) enzyme activity and content of GST-pi and P-170 glycoprotein were increased significantly compared with normal mucosa (P less than 0.03, P less than 0.003, and P less than 0.02, respectively). In contrast, GST-alpha and -mu, present in minor amounts compared with GST-pi, were downregulated in the tumor. Cytochrome P-450(4,5,6) and UDP-glucuronyltransferase (towards 4-nitrophenol and bilirubin) levels were significantly lower in the tumors (P less than 0.0001 and P less than 0.0002, respectively). Because decreased expression of cytochrome P-450 and increased levels of GST-pi and the P-170 glycoprotein have been implicated in (multi)drug resistance, these findings strongly suggest that in colorectal tumors the inherent resistance is multifactorial. Research to overcome this resistance should therefore be directed toward a combined treatment that eliminates all of these different mechanisms.
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
January 1995,
In vivo (Athens, Greece),
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
January 1990,
Bulletin du cancer,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
August 1995,
International journal of oncology,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
February 2006,
Hematology (Amsterdam, Netherlands),
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
January 1997,
American journal of rhinology,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
October 1997,
Current opinion in biotechnology,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
August 1995,
AIDS research and human retroviruses,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
July 1998,
The breast journal,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
December 1989,
Tumori,
W H Peters, and
C E Boon, and
H M Roelofs, and
T Wobbes, and
F M Nagengast, and
P G Kremers
February 2020,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
